CXCL12 and neoplasm: In hepatocellular carcinoma (HCC), combined spatial transcriptomics and proteomics uncovered CXCL12+ tumor-associated endothelial cells that mediate immunosuppression by recruiting MDSCs and inhibiting CD8+ T cells - a resistance mechanism missed in bulk analyses (Lu et al., 2025).